Founded in 2011, Carlsbad, Calif.–based Acutus Medical boasts a portfolio of electrophysiology products that includes catheter-based treatments for cardiac arrhythmias.
Roman has more than 15 years of experience in the medical technology industry. Prior to joining the company, Roman served as VP of strategy and FP&A for Baxter. He has also held numerous leadership roles at Goldman, Sachs & Co., where he led the U.S. medical technology equity research team and Morgan Stanley where he was a research analyst for the medical technology sector.
“David is an accomplished executive with a wealth of experience in healthcare, finance and strategy,” president and CEO Vince Burgess said in a news release. “His medical technology industry expertise, operational background, and depth of relationships within the investment community will strengthen our leadership team and drive the continued execution of our strategic vision.”
Gary Doherty, Acutus Medical’s current chief financial officer, will transition to the role of senior VP of finance.
“I am excited to join the Acutus team on their mission to transform patients’ lives; the company is bringing differentiated technology to the market and I look forward to working with Vince and the entire organization to lead the charge in the EP revolution,” Roman said.